KGET - CaliPharms, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0001
0.0000 (0.00%)
At close: 1:24PM EST
Stock chart is not supported by your current browser
Previous Close0.0001
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume79,542,506
Market Cap401,297
Beta (3Y Monthly)3.42
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    CaliPharms Debuts New CBD Muscle & Joint Relief Product at Marijuana Business Conference in Las Vegas

    Temecula, CA, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CaliPharms, Inc. (KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce they will debut its new CBD Muscle & Joint Relief Roll On Gel at the Marijuana Business Conference (MJBizCon) this week November 14-16th at the Las Vegas Convention Center in Las Vegas, Nevada.

  • GlobeNewswire3 days ago

    CaliPharms Launching a New CBD Muscle & Joint Relief Roll On Gel

    Temecula, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CaliPharms, Inc. (KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce that it is launching a new CBD Muscle & Joint Relief Roll On Gel. CaliPharms is proud to introduce this new CBD Muscle & Joint Relief Roll On Gel specially formulated with natural plant extracts to deliver temporary relief of muscle and joint discomfort associated with common daily activities and tough workouts!

  • GlobeNewswire2 months ago

    CaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products

    TEMECULA, CA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CaliPharms, Inc. (KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce that it has embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products. The research and development of CaliPharms initial series of naturally derived CBD (Cannabidiol) products are being developed for the overall health and wellness of athletes. CaliPharms will be offering a series of introductory CBD based products featuring several unique and novel formulas that can be considered daily staples for anyone looking to implement high quality naturally derived CBD products into their daily health and fitness regimen.

  • GlobeNewswire3 months ago

    Celebrity Fitness Expert & Formulator Joe Pavlik Joins the CaliPharms Advisory Board

    Temecula, CA, Aug. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CaliPharms, Inc. (KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce that celebrity fitness expert and formulator Joe Pavlik, has joined the Advisory Board of CaliPharms, Inc. Mr. Pavlik has extensive knowledge and experience in the health, fitness, and nutraceutical industries. CaliPharms has extensive plans to tap the resources and knowledge of Mr. Pavlik to further develop future products and innovative line extensions for CaliPharms.

  • GlobeNewswire3 months ago

    CaliPharms Enters Discussions With THC Beverage Company and CBD Producer

    Temecula, CA, Aug. 23, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CaliPharms, Inc. (KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce it is in joint venture discussions with a California and Washington based CBD producer and a California based THC Beverage company. In CaliPharms’ efforts to develop its own proprietary CBD Beverage, it is forming alliances with other successful companies within the industry.

  • GlobeNewswire3 months ago

    Beverage Master Distributor and CaliPharms Execute Definitive Purchase Agreement

    Temecula, CA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE LLC -- CaliPharms, Inc. (KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" has executed a Definitive Purchase Agreement with a Master Distributor. With One Elite Sports as part of the CaliPharms team, the Company plans to aggressively pursue the following markets in the cannabis space.